Atopic dermatitis is the most common chronic inflammatory skin disease in children and severely affects quality of life (QoL) of patients and their parents. The application of topical medications and emollient is the mainstay of the treatment, but complexity of the treatment and lack of self-care knowledge cause poor adherence, leading to therapeutic failure. Adequate education about the chronic disease and its treatment was known to improve the treatment adherence. There are a variety forms like generalized information leaflets and video clips for imparting information to patients and individualized tailoring education was considered more effective way to improve patients' adherence. The aim of this study is to determine the efficacy of tailored education in dermatology area, especially the emollient usage in patients with atopic dermatitis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
24
Parents in intervention group will receive an patient education leaflet and watch an educational video about lifestyle recommendations, and the use of emollients. In addition to general information, parents in intervention group will also receive the tailored leaflet including the estimated amount of emollients based on the body surface area.
Participants (parents of children with atopic dermatitis) in control group will receive an patient education leaflet and watch an educational video about lifestyle recommendations, and the use of emollients.
Department of Dermatology, Seoul National University Boramae Hospital
Seoul, South Korea
Change of the weekly amount of emollient used
Parents of patients are asked to bring the emollients to each visit at which time the emollients are weighed.
Time frame: Two weeks
Average daily number of emollient usage
Time frame: Two weeks
Average daily number of topical medication (other than emollient) usage
Time frame: Two weeks
Investigator's Global Assessment (IGA)
At each visit, disease severity will be assessed using the Investigator's Global Assessment (IGA).
Time frame: Two weeks
Eczema Area and Severity Index (EASI)
At each visit, disease severity will be assessed using the Eczema Area and Severity Index (EASI).
Time frame: Two weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.